Estrogen replacement therapy withdrawal and regression of metastatic breast cancer

M. V. Dhodapkar, J. N. Ingle, D. L. Ahmann

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Background. Data regarding the effects of estrogen replacement therapy (ERT) and its withdrawal in patients with breast cancer are limited. Methods. Four cases were observed involving estrogen replacement therapy withdrawal as management of metastatic breast cancer. Results. Three patients with a history of primary breast cancer developed metastatic disease while on ERT. A fourth patient presented with metastatic breast cancer while on ERT. Withdrawal of this 'physiologic' ERT alone as the only therapeutic intervention resulted in regression of metastatic disease in all four patients. Conclusions. In patients receiving ERT who develop metastatic breast cancer, withdrawal of ERT alone is a therapeutic option. Awareness of this phenomenon may be of value in management of these patients. The role of ERT and value of ERT withdrawal in patients with breast cancer deserve further study.

Original languageEnglish (US)
Pages (from-to)43-46
Number of pages4
JournalCancer
Volume75
Issue number1
DOIs
StatePublished - 1995

Fingerprint

Estrogen Replacement Therapy
Breast Neoplasms

Keywords

  • estrogen replacement therapy
  • metastatic breast cancer
  • withdrawal response

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Estrogen replacement therapy withdrawal and regression of metastatic breast cancer. / Dhodapkar, M. V.; Ingle, J. N.; Ahmann, D. L.

In: Cancer, Vol. 75, No. 1, 1995, p. 43-46.

Research output: Contribution to journalArticle

Dhodapkar, M. V. ; Ingle, J. N. ; Ahmann, D. L. / Estrogen replacement therapy withdrawal and regression of metastatic breast cancer. In: Cancer. 1995 ; Vol. 75, No. 1. pp. 43-46.
@article{8ae4c586581e445d9b67b71a85dfdb94,
title = "Estrogen replacement therapy withdrawal and regression of metastatic breast cancer",
abstract = "Background. Data regarding the effects of estrogen replacement therapy (ERT) and its withdrawal in patients with breast cancer are limited. Methods. Four cases were observed involving estrogen replacement therapy withdrawal as management of metastatic breast cancer. Results. Three patients with a history of primary breast cancer developed metastatic disease while on ERT. A fourth patient presented with metastatic breast cancer while on ERT. Withdrawal of this 'physiologic' ERT alone as the only therapeutic intervention resulted in regression of metastatic disease in all four patients. Conclusions. In patients receiving ERT who develop metastatic breast cancer, withdrawal of ERT alone is a therapeutic option. Awareness of this phenomenon may be of value in management of these patients. The role of ERT and value of ERT withdrawal in patients with breast cancer deserve further study.",
keywords = "estrogen replacement therapy, metastatic breast cancer, withdrawal response",
author = "Dhodapkar, {M. V.} and Ingle, {J. N.} and Ahmann, {D. L.}",
year = "1995",
doi = "10.1002/1097-0142(19950101)75:1<43::AID-CNCR2820750109>3.0.CO;2-#",
language = "English (US)",
volume = "75",
pages = "43--46",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Estrogen replacement therapy withdrawal and regression of metastatic breast cancer

AU - Dhodapkar, M. V.

AU - Ingle, J. N.

AU - Ahmann, D. L.

PY - 1995

Y1 - 1995

N2 - Background. Data regarding the effects of estrogen replacement therapy (ERT) and its withdrawal in patients with breast cancer are limited. Methods. Four cases were observed involving estrogen replacement therapy withdrawal as management of metastatic breast cancer. Results. Three patients with a history of primary breast cancer developed metastatic disease while on ERT. A fourth patient presented with metastatic breast cancer while on ERT. Withdrawal of this 'physiologic' ERT alone as the only therapeutic intervention resulted in regression of metastatic disease in all four patients. Conclusions. In patients receiving ERT who develop metastatic breast cancer, withdrawal of ERT alone is a therapeutic option. Awareness of this phenomenon may be of value in management of these patients. The role of ERT and value of ERT withdrawal in patients with breast cancer deserve further study.

AB - Background. Data regarding the effects of estrogen replacement therapy (ERT) and its withdrawal in patients with breast cancer are limited. Methods. Four cases were observed involving estrogen replacement therapy withdrawal as management of metastatic breast cancer. Results. Three patients with a history of primary breast cancer developed metastatic disease while on ERT. A fourth patient presented with metastatic breast cancer while on ERT. Withdrawal of this 'physiologic' ERT alone as the only therapeutic intervention resulted in regression of metastatic disease in all four patients. Conclusions. In patients receiving ERT who develop metastatic breast cancer, withdrawal of ERT alone is a therapeutic option. Awareness of this phenomenon may be of value in management of these patients. The role of ERT and value of ERT withdrawal in patients with breast cancer deserve further study.

KW - estrogen replacement therapy

KW - metastatic breast cancer

KW - withdrawal response

UR - http://www.scopus.com/inward/record.url?scp=0028839029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028839029&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19950101)75:1<43::AID-CNCR2820750109>3.0.CO;2-#

DO - 10.1002/1097-0142(19950101)75:1<43::AID-CNCR2820750109>3.0.CO;2-#

M3 - Article

C2 - 7804976

AN - SCOPUS:0028839029

VL - 75

SP - 43

EP - 46

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -